A team led by Wang Jiguang at the Hong Kong University of Science and Technology published a study online in Cell on August 3, 2026, finding ancient L1 retrotransposons upstream of many immunoglobulin heavy-chain variable region (VH) genes. B cells use the HUSH complex, normally devoted to silencing transposons, to recruit AID, making the mutation rate in VH regions 100-1000 times higher than elsewhere in the genome. In Ramos cells, the researchers inserted an ancient L1 upstream of VH4-34 and verified its function in promoting antibody diversification.
A study published in Nature Biotechnology used protein engineering to modify the botulinum neurotoxin type X protease (BoNT/X), giving it new substrate recognition capability and inducing inflammatory death in cancer cells. Conventional pyroptosis depends on caspase-1 cleavage of gasdermin D; the engineering strategy repurposes a neuron-targeting toxin for precise tumor killing.
Why it matters: The article describes engineering a botulinum toxin to induce pyroptosis in cancer cells, showing how a neurotoxin can be repurposed as a tumor-killing tool.
A UCLA team led by Thomas A. Rando reports in Science that slowed regeneration by aged muscle stem cells is not simple functional breakdown, but the result of selection favoring cells that suppress regeneration to survive long-term in the aged microenvironment. Using Pax7 promoter-driven muscle stem cell-specific NDRG1 conditional knockout mice, aged NDRG1 cKO mice showed markedly higher in vivo stem cell activation 3 days after muscle injury and significantly larger regenerating myofiber cross-sectional area at day 7, with overall regeneration speed approaching that of young mice.
Why it matters: Conditional NDRG1 knockout mice show slowed aged muscle stem cell regeneration is a survival selection outcome in the aged microenvironment, offering a new angle for aging research.
